Renal resistance index in type 2 diabetes

Diabetologia Croatica

Volumn 35, Issue 1, 2006, Pages 7-13

  Ljubić, Spomenka ^a   Brkljačic̀, Boris ^b   Metelko, Željko ^a   Pavlić Renar, Ivana ^a  

^a University of Zagreb   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

Albuminuria; Blood pressure; Diabetic nephropathy; Renal resistance index

Indexed keywords

ALBUMIN; GLYCOSYLATED HEMOGLOBIN; LIPID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HUMAN; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 33845563510     PISSN: 03510042     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999;341:1127-1133.
2. Osterby R, Tapia J, Nyberg G, Tencer J, Willner J, Rippe B, Torffvit O. Renal structures in type 2 diabetic patients with elevated albumin excretion rate. APMIS 2001;109:751-761.
3. Fioretto P, Mauer M, Carraro A, Bruseghin M, Brocco E, Crepaldi G, Nosadini R. Renal structural changes in non-insulin dependent diabetes mellitus. Am J Hypertens 1997;10:184S-188S.
4. Rossing K, Christensen PK, Jensen BR, Parvin HH. Dual blockade of the renin-angiotensin system in diabetic nephropathy. Diabetes Care 2002;25:95-100.
5. US Renal Data System USRDS 1994 Annual Data report. Incidence and causes of treated renal disease. Am J Kidney Dis 1994;24(Suppl 2):48S-56S.
6. Valderrabano F. EDTA Registry annual report on management of renal failure in Europe, XXIV, 1993. European Dialysis and Transplantation Association Annual Congress 1994, Vienna.
7. Hong YC, Chia KS. Markers of diabetic nephropathy. J Diabetes Complications 1998;12:43-60.
8. Mueller PW, Hall D, Caudill SP, MacNeil M, Arepally A. An in-depth examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension. Am J Hypertens 1995;8:1072-1082.
9. Dinneen SF, Hertzel CG. The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-1418.
10. Jarett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrell TJ. Microalbuminuria predicts mortality in non-insulin dependent diabetes. Diabet Med 1984;1:17-19.
11. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000;43:1205-1223.
12. kip1. Kidney Int 1999;56:1262-1265.
13. Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999;42:263-285.
14. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999;56:393-405.
15. Ritz E, Keller C, Bergis K, Strojek K. Pathogenesis and course of renal disease in IDDM/NIDDM. Am J Hypertens 1997;10:2028-2078.
16. Phillips AO, Janssen U, Floege J. Progression of diabetic nephropathy. Kidney Blood Press Res 1999;22:81-97.
17. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F. Muollo B, Sambataro M, Abaterosso G, Baggio B, Crepaldi G, Nosadini R. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996;39:1569-1576.
18. Chukwuma C, Sr. Type II diabetic nephropathy in perspective. J Diabetes Complications 1995;9:55-67.
19. Elliott WJ, Stein PP, Black HR. Drug treatment of hypertension in patients with diabetes. Diabetes Rev 1995;3:477-509.
20. Bakris GL. Pathogenesis of hypertension in diabetes. Diabetes Rev 1995;3:460-476.
21. Brkljacic B, Mrzljak V, Drinkovic I, Soldo D, Sabljar-Matovinovic M, Hebrang A. Renal vascular resistance in diabetic nephropathy: duplex Doppler US evaluation. Radiology 1994;192:549-554.
22. Ishimura E, Nishizawa Y, Kawagishi T, Okuno Y, Kogawa K, Fukumoto S, Maekawa K, Hosoi M, Inaba M, Emoto M, Morii H. Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney Int 1997;51:1920-1927.
23. Cvitković Kuzmić A, Brkljačić B, Ivanković D, Galešić K. Doppler sonographic renal resistance index in healthy children. Eur Radiol 2000;10:1644-1648.
24. Platt JF. Duplex Doppler evaluation of native kidney dysfunction: obstructive and non-obstructive disease. AJR 1992;158:1035-1042.
25. Conover WJ. Practical nonparametric statistics. New York: John Wiley & Sons, 1971.
26. Sokal RR, Rohlf FJ. Biometry. 3rd ed. New York: WH Freeman and Company, 1995.
27. Anderson S, Vora JP. Current concepts of renal hemodynamics in diabetes. J Diabetes Complications 1995;9:304-307.
28. Deckert T, Felt-Rasmussen B, Borch-Johnsen K. Albuminuria reflects widespread vascular damage. Diabetologia 1989;32:219-226.
29. Platt JF, Rubin JM, Ellis JH. Diabetic nephropathy: evaluation with renal duplex Doppler US. Radiology 1994;190:343-346.
30. Derchi LE, Martinoli C, Saffioti S, Pontremoli R, De Micheli A, Bordone C. Ultrasonographic imaging and Doppler analysis of renal changes in non-insulin dependent diabetes mellitus. Academic Radiol 1994;1:100-105.
31. Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998;158:998-1004.
32. Boeri D, Derchi LE, Martinoli C, Simoni G, Sampietro L, Storace D, Ponte L, Calvi C, Repetto M, Robaudo C, Maiello M. Intrarenal arteriosclerosis and impairment of kidney function in NIDDM subjects. Diabetologia 1998;41:121-124.
33. Schmitz A. Microalbuminuria, blood pressure, metabolic control, and renal involvement. Am J Hypertens 1997;10:189S-197S.
34. Parving HH. Renoprotection in diabetes: genetic and non-genetic risk factors and treatment. Diabetologia 1998;41:745-759.
35. Mostbeck GH, Kain R, Mallek R. Duplex Doppler sonography in renal parenchymal disease. J Ultrasound Med 1991;10:189-194.
36. Becker JA. Evaluation of renal function. Radiology 1991;179:337-338.
37. Nathan DM. The pathophysiology of diabetes complications: how much does the glucose hypothesis explain? Ann Intern Med 1996;124:86-89.
38. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.